[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350867-105":59,"doc-detail-350867-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","oral-keratinocyte-mediated-inflammation-and-epithelial-disruption-irf6-signaling-and-oral-carcinogenic-risk-narrative-review","Oral keratinocyte-mediated inflammation and epithelial disruption - IRF6 signaling and oral carcinogenic risk - narrative review","","Oral keratinocyte-mediated inflammation and epithelial disruption investigates how keratinocytes shape immune signaling and tissue integrity in chronic inflammatory settings. The review highlights IRF6 as a central regulator of epithelial differentiation and downstream immune pathways, linking Toll-like receptor activation, CCL5-driven inflammation, hypoxic signaling, and epithelial-mesenchymal transition to progression toward epithelial disruption and malignant transformation. It frames IRF6 modulation as a therapeutic target and sets directions for integrating molecular biomarkers and immune modulation strategies in oral pathology.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oral-keratinocyte-mediated-inflammation-and-epithelial-disruption-irf6-signaling-and-oral-carcinogenic-risk-narrative-review/350867/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oral-keratinocyte-mediated-inflammation-and-epithelial-disruption-irf6-signaling-and-oral-carcinogenic-risk-narrative-review/350867.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the review on oral keratinocytes?","Question",{"text":112,"@type":113},"The review focuses on how oral keratinocytes mediate inflammation and epithelial disruption through IRF6 signaling, linking immune pathways to epithelial behavioral changes and carcinogenic risk.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling routes are discussed in relation to TLR activation?",{"text":117,"@type":113},"It describes two adaptor-dependent TLR pathways in oral keratinocytes: the MyD88-dependent route and the TRIF-dependent route, leading to cytokine and interferon-related immune responses.",{"name":119,"@type":110,"acceptedAnswer":120},"How does IRF6 connect to inflammatory processes in the oral epithelium?",{"text":121,"@type":113},"IRF6 is presented as a key transcriptional regulator that drives expression of inflammatory mediators, including induction of CCL5, which supports T-cell recruitment and activation.",{"name":123,"@type":110,"acceptedAnswer":124},"Why is modulation of IRF6 considered a therapeutic target?",{"text":125,"@type":113},"By regulating epithelial integrity and inflammatory progression, targeting IRF6 signaling is proposed as a way to restore barrier function and halt disease progression in chronic inflammatory oral conditions.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},350867,1791095904,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Oral keratinocyte-mediated inflammation and epithelial disruption: A narrative review on IRF6 signaling and oral carcinogenic risk  \nInternational Journal of Immunopathology and Pharmacology Volume 40: 1–13  \n© The Author(s) 2026  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320251411432](DOI: 10.1177/03946320251411432)[ ](DOI: 10.1177/03946320251411432)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nYuliana Andrea Osorio-Osorno and Monica Tatiana Parada-Sanchez  \nAbstract  \nThe oral epithelium is a dynamic interface between host and environment, where keratinocytes not only serve as structural components but also actively modulate immune responses. Emerging research identifies IRF6 as a pivotal regulator of epithelial differentiation and immune signaling within chronic inflammatory contexts. This narrative review explores the role of IRF6 and its downstream effects in oral keratinocytes, particularly in relation to Toll-like receptor (TLR) activation, CCL5-mediated inflammation, hypoxic signaling, and the epithelial-mesenchymal transition (EMT). It proposes a mechanistic framework for understanding the progression from chronic inflammation to epithelial disruption and malignant transformation in oral mucosal disorders. Modulation of IRF6 signaling represents a promising therapeutic target for restoring epithelial integrity and halting disease progression in chronic inflammatory oral diseases. This model lays groundwork for future research integrating molecular biomarkers and immune modulation strategies in oral pathology.  \nKeywords  \noral keratinocytes, chronic inflammation, epithelial-mesenchymal transition, oral squamous cell carcinoma, oral lichen planus  \nDate received: 27 July 2025; accepted: 12 December 2025  \nIntroduction  \nHead and neck cancer (HNC) represents the sixth most common malignancy worldwide. 1,2 Among the various subtypes, oral squamous cell carcinoma (OSCC) accounts for most cases.2 While tobacco smoking and excessive alcohol consumption remain the most prominent and well-established risk factors for OSCC, 1,3 a growing subset of patients, classified as non-smoking and non-drinking (NSND), develop the disease in the absence of these traditional exposures. In such cases, alternative etiological factors such as chronic trauma and dysbiosis of the oral microbiome have been proposed.4  \nThe oral epithelium functions as a critical interface between the host and the external environment. Oral keratinocytes, the predominant cell type in this  \nbarrier, play a dual role: they provide a physical defense against external insults and contribute to immune surveillance. This immunological function is largely mediated by pattern recognition receptors, particularly Toll-like receptors (TLRs), which enable keratinocytes to detect microbial components and initiate immune responses.5,6 Upon activation, TLRs orchestrate a finely balanced immune reaction by regulating the production of pro-inflammatory and anti-inflammatory mediators.7 Specifically,  \nSchool of Dentistry, Universidad de Antioquia, Medellín, Colombia  \nCorresponding author:  \nYuliana Andrea Osorio-Osorno, School of Dentistry, Universidad de Antioquia, Calle 64 No. 52-59, Bloque 31, Medellin, Colombia. [Email: yulianaa.osorio@udea.edu.co](Email: yulianaa.osorio@udea.edu.co)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nTLR activation in","cbCaipdjykSVq8ze","https://ap.wps.com/l/cbCaipdjykSVq8ze","pdf",852599,13,"English","# Introduction\n# Oral epithelium as host-environment interface\n## Role of keratinocytes in immune surveillance\n## Toll-like receptor (TLR) activation and adaptor pathways\n# IRF6 in epithelial biology and inflammation\n## Regulation downstream of TLR2/MyD88–IRAK1\n## CCL5 induction and inflammatory amplification\n# Narrative review aims and scope","[{\"question\":\"What is the main focus of the review on oral keratinocytes?\",\"answer\":\"The review focuses on how oral keratinocytes mediate inflammation and epithelial disruption through IRF6 signaling, linking immune pathways to epithelial behavioral changes and carcinogenic risk.\"},{\"question\":\"Which signaling routes are discussed in relation to TLR activation?\",\"answer\":\"It describes two adaptor-dependent TLR pathways in oral keratinocytes: the MyD88-dependent route and the TRIF-dependent route, leading to cytokine and interferon-related immune responses.\"},{\"question\":\"How does IRF6 connect to inflammatory processes in the oral epithelium?\",\"answer\":\"IRF6 is presented as a key transcriptional regulator that drives expression of inflammatory mediators, including induction of CCL5, which supports T-cell recruitment and activation.\"},{\"question\":\"Why is modulation of IRF6 considered a therapeutic target?\",\"answer\":\"By regulating epithelial integrity and inflammatory progression, targeting IRF6 signaling is proposed as a way to restore barrier function and halt disease progression in chronic inflammatory oral conditions.\"}]","Oral keratinocyte-mediated inflammation and epithelial disruption - IRF6 signaling and oral carcinogenic risk - narrative review | PDF",1790091604,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdab979a2fb30002029583f7011efd8c.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9456b9777511e1acfa0294919f54b10.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dfe1ba1016bcefd5191f664798f0fdc.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12dac97f9197df7ae53cd60de96c2853.webp",980,1306]